Dagrocorat (developmental code names PF-00251802, PF-251802) is a nonsteroidal but steroid-like selective glucocorticoid receptor modulator (SGRM) which was under development for the treatment of rheumatoid arthritis but was never marketed. It is described as a partial agonist and "dissociable" agonist of the glucocorticoid receptor. The drug reached phase I clinical trials prior to the discontinuation of its development. The C2α dihydrogen phosphate ester of dagrocorat, fosdagrocorat, was also under investigation, but its development was terminated as well. See also AZD-5423 Mapracorat Fosdagrocorat References External links Dagrocorat - AdisInsight Anti-inflammatory agents Carboxamides Glucocorticoids Phenanthrenes Phenyl compounds Pyridines Selective glucocorticoid receptor modulators Trifluoromethyl compounds